These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1221589)

  • 1. [Long-term treatment of middle-aged and old patients with paralysis agitans and parkinsonism with levodopa].
    Bogolepov NK; Gorbunov FE
    Vrach Delo; 1975 Aug; (8):126-30. PubMed ID: 1221589
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term effects of home-made levodopa in 43 cases of paralysis agitans.
    Liu D; Jiang Y
    Chin Med J (Engl); 1979 Nov; 92(11):807-10. PubMed ID: 116825
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term results of L-dopa treatment of parkinsonism].
    Barbeau A
    Union Med Can; 1975 Jan; 104(1):32-8. PubMed ID: 1111195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (6) Problems of long-term treatment of levodopa in parkinsoism].
    Uono K
    Rinsho Shinkeigaku; 1976 Dec; 16(12):881-2. PubMed ID: 828568
    [No Abstract]   [Full Text] [Related]  

  • 5. [Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis].
    Borromei A; Manzini A
    Minerva Med; 1974 Nov; 65(79):4160-70. PubMed ID: 4610450
    [No Abstract]   [Full Text] [Related]  

  • 6. Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise.
    Manyam BV
    Mov Disord; 1990; 5(1):47-8. PubMed ID: 2404203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects and side effects of levodopa in parkinsonism - results of a collaborative study. (2) The relationship between the age of the onset and therapeutic effects].
    Yokochi M
    Rinsho Shinkeigaku; 1976 Dec; 16(12):871-3. PubMed ID: 1035528
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of L-dopa treatment in parkinsonism (author's transl)].
    Kolasa M; Reichowa J; Bieniowa A
    Przegl Lek; 1976; 33(3):407-10. PubMed ID: 1273335
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of chronic levodopa therapy in Parkinson's disease.
    Battistin L; Bracco F; Saladini M
    J Neural Transm Suppl; 1986; 22():201-7. PubMed ID: 3465871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Madopar in the treatment of paralysis agitans: II. TRH activation test, EMG examination and HVA level in cerebrospinal fluid before and after treatment].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):223-6. PubMed ID: 6790255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Motor fluctuations in Parkinson disease: risk factors].
    Grandas F; Luquin MR; Rodríguez M; Vaamonde J; Lera G; Obeso JA
    Neurologia; 1992 May; 7(5):89-93. PubMed ID: 1389297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
    Miranda M; Saéz D
    Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young onset Parkinson's disease.
    Quinn N; Critchley P; Marsden CD
    Mov Disord; 1987; 2(2):73-91. PubMed ID: 3504266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Madopar in the treatment of paralysis agitans. I. Therapeutic efficacy and side-effects in 56 cases (author's transl)].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980; 13(3):147-50. PubMed ID: 7438902
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinsonism following dystonia in three patients.
    Katchen M; Duvoisin RC
    Mov Disord; 1986; 1(2):151-7. PubMed ID: 3504239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].
    Goulley F; Wolmark Y; Bourdeix I; Chaumet-Riffaud PD
    Therapie; 1993; 48(3):233-8. PubMed ID: 7908147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent levodopa therapy in parkinsonism.
    Koller WC
    Adv Neurol; 1983; 37():45-50. PubMed ID: 6407286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citicoline in the treatment of Parkinson's disease.
    Eberhardt R; Birbamer G; Gerstenbrand F; Rainer E; Traegner H
    Clin Ther; 1990; 12(6):489-95. PubMed ID: 2289218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of two malignant melanomas during administration of levodopa.
    Przybilla B; Schwab U; Landthaler M; Braun-Falco O
    Acta Derm Venereol; 1985; 65(6):556-7. PubMed ID: 2420127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinsonism treated with levodopa: progression and mortality.
    Maier Hoehn MM
    J Neural Transm Suppl; 1983; 19():253-64. PubMed ID: 6583311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.